Article
N6-methyladenosine modification of DYNLT1 Facilitates Tamoxifen Resistance in Luminal B Breast Cancer
2024-11-01
Abstract excerpt
<title>Abstract</title> <p>Purpose Resistance to tamoxifen poses a significant clinical challenge in the management of Luminal B breast cancer, necessitating the identification of novel biomarkers for predicting treatment response and prognosis. The specific role of DYNLT1 in endocrine response within Luminal B breast cancer remains uncertain. Methods The expression levels of DYNLT1 were assessed in breast canc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- be1767e0-a127-53a4-89f4-507a394851e2
- DOI
- 10.21203/rs.3.rs-5295457/v1
